Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Proto Script Pharmaceutical's Revenue for the
three
months ended in Sep. 2017 was $0.25 Mil. Proto Script Pharmaceutical's average Accounts Receivable for the
three
months ended in Sep. 2017 was $0.14 Mil.
Hence, Proto Script Pharmaceutical's Receivables Turnover for the
three
months ended in Sep. 2017 was 1.87.
Proto Script Pharmaceutical (OTCPK:PSCR) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Proto Script Pharmaceutical Receivables Turnover Related Terms
Proto Script Pharmaceutical Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proto Script Pharmaceutical Receivables Turnover Chart
PSCR vs EXCC, NXES, PRZM: Receivables Turnover Comparison
For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Proto Script Pharmaceutical Receivables Turnover vs Business Services Industry
For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Proto Script Pharmaceutical's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proto Script Pharmaceutical (PSCR) has a Receivables Turnover of 1.87 as of Sep. 2017. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Receivables Turnover too high?
Proto Script Pharmaceutical's current Receivables Turnover is 1.87. The Business Services industry median Receivables Turnover is 6.26. Proto Script Pharmaceutical's value of 1.87 is 70.1% below this industry median.
How does Proto Script Pharmaceutical's Receivables Turnover compare to EXCC and NXES?
Proto Script Pharmaceutical's Receivables Turnover of 1.87 can be compared against companies in the Business Services industry. The industry median Receivables Turnover is 6.26. Proto Script Pharmaceutical's value of 1.87 is 70.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Business Services company?
The median Receivables Turnover among Business Services companies is 6.26, based on 1,062 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Proto Script Pharmaceutical's current Receivables Turnover of 1.87 is 70.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Proto Script Pharmaceutical and its competitors. For the Business Services industry, the median Receivables Turnover is 6.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proto Script Pharmaceutical's current Receivables Turnover is 1.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Receivables Turnover of 1.87. The current Receivables Turnover is 1.87 and 70.1% below the Business Services industry median of 6.26. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Receivables Turnover is 1.87 as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PSCR has been successfully added to your 
